ChartRow logo
GH
Guardant Health Inc.Stock · Health Care · Russell 2000 0.4%
$159.62−$5.50 (-3.33%)as of market close, Aug 13, 2026
☾ After hours:$159.54+0.00%3:59 PM ET
CompareLLYUNHJNJABBVISRGTMO

GH financial statements

The full income statement, balance sheet, and cash-flow statement for Guardant Health Inc. (GH), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 123.0M2024-09 123.6M2024-12 123.4M2025-03 123.9M2025-06 124.7M2025-09 126.0M2025-12 131.2M2026-03 132.6M2026-06 134.2M+9.1% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue
982M
YoY+32.9%
739M
YoY+31.0%
564M
YoY+25.5%
450M
YoY+20.3%
374M
YoY+30.3%
Cost of revenue
349M
YoY+20.4%
290M
YoY+27.6%
227M
Research & development
364M
YoY+4.7%
348M
YoY-5.3%
367M
YoY-1.8%
374M
YoY+42.0%
263M
YoY+75.6%
Selling, general & administrative
211M
YoY+17.4%
180M
YoY+15.6%
156M
YoY-5.0%
164M
YoY-20.7%
207M
YoY+7.2%
General & administrative
211M
YoY+17.4%
180M
YoY+15.6%
156M
YoY-5.0%
164M
YoY-20.7%
207M
YoY+7.2%
Selling & marketing
495M
YoY+35.5%
365M
YoY+23.6%
295M
YoY-1.5%
300M
YoY+56.3%
192M
YoY+80.1%
Amortization of intangibles
1.70M
YoY-22.7%
2.20M
YoY-18.5%
2.70M
YoY+8.0%
2.50M
YoY+31.6%
1.90M
YoY+5.6%
Operating income
-437M
YoY+1.4%
-444M
YoY+21.4%
-565M
YoY-3.7%
-544M
YoY-32.5%
-411M
YoY-61.2%
Interest expense
3.90M
YoY+51.0%
2.58M
YoY+0.1%
2.58M
YoY+0.0%
2.58M
YoY+0.0%
2.58M
YoY-45.9%
Interest & investment income
34.1M
YoY-36.5%
53.7M
YoY+51.8%
35.4M
YoY+482.7%
6.07M
YoY+54.4%
3.93M
YoY-61.4%
Other non-operating income
-10.5M
YoY+75.4%
-42.6M
YoY-180.1%
53.2M
YoY+516.1%
-12.8M
YoY-150.8%
25.2M
YoY+591.5%
Gain (loss) on equity securities
0.00
YoY+100.0%
-44.4M
YoY-155.7%
79.7M
YoY+1122.8%
-7.79M
0.00
Pre-tax income
-418M
YoY+4.0%
-435M
YoY+9.1%
-479M
YoY+26.7%
-653M
YoY-70.0%
-384M
YoY-56.3%
Income tax
-1.26M
YoY-198.4%
1.28M
YoY+87.4%
685K
YoY-39.9%
1.14M
YoY+279.7%
300K
YoY-20.8%
-416M
YoY+4.6%
-436M
YoY+9.0%
-479M
YoY+26.8%
-655M
YoY-70.1%
-385M
YoY-56.2%
-$3.32
YoY+6.7%
-$3.56
YoY+16.8%
-$4.28
YoY+33.2%
-$6.41
YoY-60.3%
-$4.00
YoY-53.8%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
1.47B
YoY+38.9%
1.06B
YoY-21.7%
1.35B
YoY+13.1%
1.19B
YoY+7.0%
1.11B
YoY-41.0%
2.01B
YoY+35.5%
1.49B
YoY-16.8%
1.79B
YoY+11.0%
1.61B
YoY-27.0%
2.20B
YoY-3.0%
303M
YoY+34.2%
226M
YoY+9.6%
206M
YoY+6.6%
193M
YoY-0.8%
195M
YoY+191.4%
2.11B
YoY+30.0%
1.63B
YoY-0.2%
1.63B
YoY+5.0%
1.55B
YoY-0.6%
1.56B
YoY+70.2%
-99.3M
YoY+28.9%
-140M
YoY-188.0%
159M
YoY+163.7%
60.2M
YoY-90.7%
645M
YoY-50.3%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
-185M
YoY+23.0%
-240M
YoY+26.2%
-325M
YoY-5.0%
-309M
YoY-48.1%
-209M
YoY-101.1%
-627M
YoY-140.0%
-261M
YoY-131.1%
840M
YoY+460.9%
150M
YoY+337.2%
-63.2M
YoY+89.8%
671M
YoY+67482.8%
-996K
YoY-100.2%
477M
YoY+352.5%
-189M
YoY-183.0%
-66.8M
YoY-104.7%
Net change in cash
-140M
YoY+72.2%
-504M
YoY-150.8%
992M
YoY+383.1%
-350M
YoY-2.8%
-341M
YoY-149.4%
Interest paid
3.77M
0.00
0.00
0.00
Income taxes paid
869K
YoY-13.7%
1.01M
YoY-48.9%
1.97M
YoY+47.9%
1.33M
YoY+238.7%
393K
YoY+18.7%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap
13.4B
YoY+255.3%
3.77B
YoY+18.1%
3.19B
YoY+14.6%
2.79B
YoY-72.7%
10.2B
YoY-21.3%
P/S
13.6×
YoY+167.4%
5.1×
YoY-14.4%
6.0×
YoY-7.9%
6.5×
YoY-76.3%
27.3×
YoY-39.6%
P/B
14.0×
YoY-16.3%
16.7×
YoY+5.8%
15.8×
YoY+58.5%
Source filing10-K10-K10-K10-K10-K

About this data

Source: GH's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all GH filings on SEC EDGAR → Not investment advice.